ABSORPTION, EXCRETION, AND METABOLISM OF A NEW ANTIBACTERIAL AGENT, NALIDIXIC ACID.
D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents; D035843:Biomedical Research; D001769:Blood; D005243:Feces; D005441:Fluids and Secretions; D007408:Intestinal Absorption; D008660:Metabolism; D009268:Nalidixic Acid; D009287:Naphthyridines; D014556:Urine
D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents; D009287:Naphthyridines; D009268:Nalidixic Acid
ANTI-INFECTIVE AGENTS; BLOOD; CLINICAL RESEARCH; EXCRETION; FECES; INTESTINAL ABSORPTION; METABOLISM; NALIDIXIC ACID; NAPHTHYRIDINES; URINE